Madison Small Cap Divests from Cogent Communications Due to Strategic Concerns
Money

Madison Small Cap Divests from Cogent Communications Due to Strategic Concerns

authorBy Natalie Pace
DateMar 16, 2026
Read time3 min

Madison Small Cap Fund recently decided to divest its holdings in Cogent Communications Holdings, Inc. (CCOI), a move detailed in its fourth-quarter 2025 investor letter. This decision stems from a reevaluation of the investment thesis, particularly in light of CCOI's temporary suspension of its dividend and persistent high leverage. The fund had initially anticipated a dividend reduction alongside a reestablishment of EBITDA growth, which would have stabilized the company's financial standing after integrating assets from T-Mobile. However, the complete suspension of dividends shifted the stock's valuation dynamics, leading Madison to step back until there is clear evidence of improved financial leverage.

Madison Small Cap's Strategic Reassessment of Cogent Communications Holdings (CCOI) Investment

In the fourth quarter of 2025, Madison Small Cap Fund, an investment advisory firm, announced its decision to withdraw its investment from Cogent Communications Holdings, Inc. (NASDAQ: CCOI). This strategic shift was formally communicated in the fund's investor letter, highlighting a divergence from their initial investment premise. Madison's original projection for CCOI was predicated on the company implementing a dividend cut, which was largely expected by the market, combined with a resurgence in its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). These anticipated measures were intended to mitigate the increased debt burden CCOI had incurred following its acquisition and integration of assets from T-Mobile.

However, the actual events unfolded differently. Instead of a cut, Cogent Communications opted for a temporary suspension of its dividend, a decision that Madison acknowledges as financially prudent for the company. Despite this, the absence of a dividend, which previously served as a 'valuation ballast,' significantly altered the investment landscape for Madison. The fund noted that without this steadying factor, CCOI's stock would primarily trade on an uncertain EBITDA multiple, making it susceptible to considerable price fluctuations due to minor changes in market sentiment or financial performance, especially given the company's elevated debt levels. As a result, Madison Small Cap Fund has chosen to observe from the sidelines, awaiting substantial improvements in CCOI's leverage position before reconsidering any future investment.

This situation underscores the critical importance of a well-defined investment thesis and the agility required to adapt when market conditions or company strategies deviate from expectations. Madison Small Cap's move from Cogent Communications serves as a prudent example of how fund managers reassess their positions, prioritizing long-term stability and risk management in volatile market conditions. For investors, this highlights the necessity of closely monitoring a company's financial health, particularly its dividend policies and debt levels, as these factors can profoundly impact stock valuation and investment returns.

More Articles
Encompass Health Corporation's Q4 Performance: A Deeper Look into Madison Small Cap Fund's Perspective
Madison Small Cap Fund's Q4 2025 investor letter revealed challenges, with the fund underperforming its benchmark, the Russell 2000 Index. Healthcare was the weakest sector, notably impacting Encompass Health Corporation (EHC), a leading inpatient rehabilitation services provider. Despite strong fundamentals, EHC's defensive nature clashed with a market seeking offense. The fund remains cautiously optimistic about the speculative market losing momentum. This article delves into these findings and broader market implications.
By Natalie PaceMar 16, 2026
Eli Lilly's Eczema Drug Shows Strong Skin Clearance In Phase 3 Pediatric Trial
Eli Lilly and Co. announced positive results from its Phase 3 ADorable-1 trial for Ebglyss (lebrikizumab-lbkz) in pediatric patients with moderate-to-severe atopic dermatitis, showing significant skin improvement and itch relief, with a safety profile consistent with previous studies. The company plans to submit these data to regulators for a potential label update.
By Natalie PaceMar 16, 2026
Teradyne's Strong Market Performance Outshines Dow Jones
Teradyne, a prominent semiconductor company, has demonstrated exceptional market performance, significantly outpacing the Dow Jones Industrial Average. Despite a recent dip from its 52-week high, the company's stock has surged over the past three months and half-year, trading consistently above its key moving averages. This growth is attributed to its strategic focus on portfolio optimization and market expansion, reinforcing its leadership in the semiconductor equipment industry.
By Natalie PaceMar 16, 2026
Top CD Annual Percentage Yields for March 2026
As of March 2026, Certificate of Deposit (CD) rates remain significantly higher than the national average. With the Federal Reserve having lowered its target interest rate three times in 2025, now is a prime opportunity for investors to secure favorable rates before they potentially decrease further. This article highlights the leading CD rates available today and offers guidance on identifying the most advantageous offers.
By Mr. Money MustacheMar 16, 2026
Urgently Inc. Experiences Remarkable Premarket Surge Amidst Acquisition News and Robust Earnings
Urgently Inc. (NASDAQ: ULY) shares have seen a dramatic increase of over 159% in premarket trading. This surge follows the announcement of an agreement to be acquired by Agero for $5.50 per share in cash, coupled with the company reporting better-than-expected fourth-quarter financial results. The company's reported quarterly loss of $1.97 per share surpassed analyst estimates of $3.06, while sales of $33.292 million also exceeded the consensus of $31.800 million. This positive news has significantly impacted investor confidence, leading to a substantial rally in its stock price.
By JL CollinsMar 16, 2026